This brand name is authorized in Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia
The drug VOLUVEN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
HAES
UNII 1GVO236S58 - HYDROXYETHYL STARCH 130/0.4
|
|
|
|
2
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12CA01 | Sodium chloride | A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CA Sodium |
| B05AA07 | Hydroxyethylstarch | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 9487H |
| Country: CA | Health Products and Food Branch | Identifier(s): 02278057 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 30112-02-12 |
| Country: EE | Ravimiamet | Identifier(s): 1111172, 1111194, 1111206, 1111475, 1111486, 1262258, 1262269, 1262281, 1311310, 1311321, 1311332 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 64001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 001881, 066287 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 67941758 |
| Country: HK | Department of Health Drug Office | Identifier(s): 50474 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3319408A1020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1010360, 1010361, 1065697, 1065698, 1065699, 1065700, 1065701, 1065702, 1065703, 1065704, 1065705, 1065706, 1065707, 1065708, 1065709, 1065710, 1065711, 1065712 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14580810 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 43826 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10568 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100108622, 100231713 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W57705001, W57705002, W57705003, W57705004, W57705006, W57705007, W57705008, W57705009, W57705010, W57705011, W57705012, W57705013, W57705014, W57705015, W57705016, W57705017, W57705018 |
| Country: SG | Health Sciences Authority | Identifier(s): 12297P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 3153041H |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
